本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

德康医疗

58.57
+0.51000.88%
成交量:31.70万
成交额:1,840.10万
市值:228.43亿
市盈率:32.60
高:58.77
开:58.23
低:57.20
收:58.06
52周最高:93.25
52周最低:54.11
股本:3.90亿
流通股本:3.90亿
量比:0.82
换手率:0.08%
股息:- -
股息率:- -
每股收益(TTM):1.80
每股收益(LYR):1.46
净资产收益率:30.63%
总资产收益率:7.02%
市净率:8.38
市盈率(LYR):40.01

数据加载中...

2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/10/27

重要事件披露

Form 8-K - Current report
2025/09/16

重要事件披露

Form 8-K - Current report
2025/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities